Pharmaceutical Preparations · DE · CIK 1422143
Develops targeted small-molecule cancer therapies for oncology and hematology
Comparable business profile · signals at a glance
In the 90 days to Jan 27, 2026: 7 sold $1.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 27, 2026 | Powl Brian T.Chief Commercial Officer | Sell | 4,842 | $8.46 | $41K |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sell | 4,777 | $8.46 | $40K |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sell | 4,096 | $8.46 | $35K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 3,655 | $8.46 | $31K |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sell | 2,335 | $8.46 | $20K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 2,233 | $8.46 | $19K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 2,226 | $8.46 | $19K |
| Jan 27, 2026 | Ford KathleenChief Operating Officer | Sell | 1,813 | $8.46 | $15K |
| Jan 27, 2026 | Powl Brian T.Chief Commercial Officer | Sell | 1,572 | $8.46 | $13K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 1,341 | $8.46 | $11K |
| Jan 27, 2026 | Burrows FrancisChief Scientific Officer | Sell | 1,311 | $8.46 | $11K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 1,114 | $8.46 | $9K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 951 | $8.46 | $8K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 881 | $8.46 | $7K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 695 | $8.46 | $6K |
| Dec 18, 2025 | Burrows FrancisChief Scientific Officer | Sell | 23,726 | $9.78 | $232K |
| Dec 9, 2025 | Hasnain FaheemDirector | Sell | 10,000 | $10.98 | $110K |
| Nov 14, 2025 | Leoni MollieChief Medical Officer | Sell | 15,485 | $11.18 | $173K |
| Nov 14, 2025 | Powl Brian T.Chief Commercial Officer | Sell | 8,887 | $11.18 | $99K |
| Nov 14, 2025 | Bair Teresa BrophyChief Legal Officer | Sell | 8,804 | $11.18 | $98K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.